Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.08893 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.44168 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.2609 | 69 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.55553 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.74024 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.87083 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.48615 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.74066 | 73 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.43875 | 71 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.47181 | 71 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.45383 | 71 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.49044 | 71 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.71005 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.48094 | 71 |